Intravenous Solution Market Overview
The Intravenous Solution Market is expanding as rising surgical and inpatient procedure volumes, chronic disease prevalence, aging populations, and the migration of infusion therapies into home-care settings increase demand for sterile intravenous products. Supply-chain resilience and packaging modernization are also becoming major market priorities following recent disruptions in IV fluid availability.
According to the Market Research Future report updated September 7, 2026, the global Intravenous Solution Market reached USD 14.48 billion in 2025 and is projected to grow from USD 15.27 billion in 2026 to USD 24.57 billion by 2035, registering a CAGR of 5.43% during the forecast period 2026–2035. North America held the largest regional share at 36.6% of 2025 revenue, while Asia-Pacific is the fastest-growing region at a projected CAGR of 7.42%. Total Parenteral Nutrition dominated the type segment with a 57.4% revenue share, while Peripheral Parenteral Nutrition is growing at 8.84% CAGR. Saline Solutions accounted for 48.9% of composition revenue, whereas Lipid Emulsions are the fastest-growing composition category at 9.65% CAGR. Hospitals and Clinics generated USD 9.24 billion in 2025, while Home-Care Settings are projected to grow at 8.15% CAGR.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Key players driving innovation and competitiveness in the Intravenous Solution Market include:
Baxter International
Fresenius Kabi
B. Braun Melsungen
Otsuka Pharmaceutical Factory
ICU Medical
Sichuan Kelun Pharmaceutical
Terumo Corporation
Nipro Corporation
Grifols
Pfizer (Hospira)
Amanta Healthcare
JW Life Science
The Intravenous Solution Market is being reshaped by supply-chain resilience, manufacturing localization, and the transition toward sustainable packaging. The 2024 U.S. IV fluid shortage highlighted the risks associated with concentrated manufacturing capacity and has encouraged investment in domestic production and multi-site redundancy. In Europe, restrictions on DEHP plasticizers are accelerating the transition from conventional PVC containers toward multilayer polyolefin and other non-PVC packaging. Manufacturers are also investing in blow-fill-seal technology, automated compounding, smart-pump interoperability, and integrated electronic health record workflows to improve safety and operational efficiency.
The Intravenous Solution Market can be segmented by Nutrition Type, Solution Composition, Packaging Material, End User, and Region. By nutrition type, the market includes Total Parenteral Nutrition and Peripheral Parenteral Nutrition, with Total Parenteral Nutrition representing the largest segment. By solution composition, major categories include Saline Solutions, Carbohydrate Solutions, Amino Acid Solutions, Lipid Emulsions, and Vitamins and Trace Elements. By packaging material, the market includes PVC Plastic Bags, Non-PVC Polyolefin Bags, Glass Bottles, and Other Formats. Hospitals and Clinics represent the largest end-user segment, followed by Ambulatory Surgical Centres and Home-Care Settings.
Significant opportunities are emerging from automated compounding platforms, non-PVC packaging, specialty nutrition products, local sterile manufacturing, home infusion, and resilience-focused supply contracts. Lipid emulsions and other specialized nutritional formulations offer higher-value opportunities than commodity crystalloids, while automated compounding systems can create recurring revenue through equipment and consumables. Asia-Pacific also presents significant potential as hospital capacity expands and governments encourage domestic pharmaceutical and sterile manufacturing.
Recent Developments and Market Trends:
Domestic manufacturing investments are increasing as healthcare systems seek to reduce dependence on concentrated IV fluid production and strengthen supply continuity.
Non-PVC polyolefin containers are gaining momentum as European regulatory requirements and sustainability initiatives accelerate the replacement of DEHP-containing packaging.
Automated compounding systems integrated with electronic health records are improving the accuracy, efficiency, and traceability of parenteral nutrition preparation.
Home infusion is expanding as healthcare providers and payers shift selected therapies and long-term nutritional support away from inpatient settings.
Smart-pump interoperability and infusion data analytics are creating opportunities for suppliers to combine IV solutions with digital medication-safety and clinical decision-support platforms.
Reasons to Buy the Report:
Understand the projected expansion of the Intravenous Solution Market from USD 14.48 billion in 2025 to USD 24.57 billion by 2035.
Evaluate the competitive landscape and strategic positioning of leading IV solution, parenteral nutrition, packaging, and infusion technology companies.
Identify the dominant and fastest-growing nutrition type, composition, packaging, end-user, and regional segments.
Assess the impact of supply-chain disruptions, domestic capacity investment, sustainability regulations, home infusion, and healthcare infrastructure expansion.
Gain strategic insights into non-PVC packaging, automated compounding, specialty nutrition, local manufacturing partnerships, and resilience-focused supply strategies.
Future Outlook:
The Intravenous Solution Market is expected to maintain steady growth through 2035 as surgical volumes, inpatient care, chronic disease management, nutritional support, and home infusion continue to generate demand for sterile fluid products. Total Parenteral Nutrition will remain the dominant nutrition type with a 57.4% revenue share, supported by critical care, oncology, and intestinal-failure management, while Peripheral Parenteral Nutrition is projected to grow faster at 8.84% CAGR as short-stay protocols and less invasive nutritional support expand. Saline Solutions will remain the largest composition category at 48.9% share, reflecting their widespread use for hydration, resuscitation, and drug dilution, while Lipid Emulsions are expected to be the fastest-growing composition segment at 9.65% CAGR. PVC Plastic Bags currently account for the largest packaging share at 43.4%, but Non-PVC Polyolefin Bags are projected to grow rapidly at 10.07% CAGR as sustainability requirements and DEHP restrictions accelerate packaging conversion. Hospitals and Clinics will remain the largest end-user segment, generating USD 9.24 billion in 2025, while Home-Care Settings are expected to record the fastest growth at 8.15% CAGR as infusion therapy and long-term nutrition increasingly migrate outside hospitals. North America will retain regional leadership with 36.6% of 2025 revenue, supported by high fluid consumption, advanced healthcare infrastructure, and substantial investments in domestic manufacturing resilience, while Asia-Pacific will remain the fastest-growing region at 7.42% CAGR as India, China, and other markets expand tertiary hospital capacity and local sterile production. Overall, supply-chain localization, sustainable packaging, automated compounding, specialty nutrition, smart-pump integration, and home-care migration are expected to drive the Intravenous Solution Market to USD 24.57 billion by 2035.
➤➤Explore Our Latest Related Reports:
